Alnylam Pharmaceuticals
ALNY
#638
Rank
$39.88 B
Marketcap
$298.76
Share price
-4.49%
Change (1 day)
-5.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company